Companies House · 04325685

GEDEON RICHTER (UK) LIMITED

UK registered company, private limited company, incorporated 20 Nov 2001.

Active
50
Public contracts
0
Spend payments
Total spend

GEDEON RICHTER (UK) LIMITED is a UK company registered at Companies House under number 04325685. This page links its registry record to its activity in UK public procurement — the contracts it has been awarded and the transparency-spend payments recorded against it.

Companies House record

Company number
04325685
Status
Active
Company type
Private Limited Company
Incorporated
20 Nov 2001
Country of origin
United Kingdom
Registered office
127 SHIRLAND ROAD, LONDON, W9 2EP
Nature of business (SIC)
46180 - Agents specialized in the sale of other particular products; 46460 - Wholesale of pharmaceutical goods
Accounts category
FULL
View source on data.gov.uk

Public sector contracts

Contract awards linked to GEDEON RICHTER (UK) LIMITED.

ProcurementBuyerAwardedValue
Biologic and Biosimilar MedicineseTenderwales
Gastrointestinal, Endocrine, Nutrition & Blood MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
NP49425 Generic and Biosimilar Transition MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
NHS Framework for the Midlands and East, Branded Medicines – Tranche B plus Cytokine Modulators and other Monoclonal Antibodies.The NHS Commissioning Board (operating under the name of NHS England)
NHS Framework, North of England, Branded Medicines - Tranche A and Annual TrancheThe NHS Commissioning Board (operating under the name of NHS England)
NHS South of England Branded Medicines - Tranche A - September 2023NHS England
NHS Framework Agreement, Branded Medicines for London and South of England and Bevacizumab for North of England and Midlands and EastNHS England
NHS Framework Agreement, Branded Medicines for London and South of England and Bevacizumab for North of England and Midlands and EastNHS England
Medicinal Products and Pharma Funded Homecare Services (5315742) - Pre - Market EngagementRegional Business Services Organisation Procurement and Logistics Service
Medicinal Products and Pharma Funded Homecare Services (5315742) - Pre - Market EngagementRegional Business Services Organisation Procurement and Logistics Service
Medicinal Products and Pharma Funded Homecare ServicesProcurement and Logistics Service
Medicinal Products and Pharma Funded Homecare ServicesProcurement and Logistics Service
NP49425 Generic and Biosimilar Transition MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
NP49425 Generic and Biosimilar Transition MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
NHS Branded Medicines Tranche Framework for London and South of England - 1 September 2024NHS England
Invitation to offer for NHS Framework Agreement for Branded Medicines - Proprietary Category Tender - 01 May 2025NHS England
NHS Framework Agreement for Branded Medicines – Tranche A London and South of England and Adult Influenza (National) - 01 September 2025NHS England
NHS South of England Branded Medicines - Tranche B and AnnualNHS England
Invitation to offer for NHS London Branded Medicines - Tranche A and AnnualNHS England
Invitation to offer for NHS Framework for the North of England, Branded Medicines – Tranche B, Annual Tranche and Insulin Aspart Biosimilar (Trurapi®)The NHS Commissioning Board (operating under the name of NHS England)
NHS National Framework for Denosumab Injection commencing 1st January 2026NHS England
NHS Framework for the Midlands and East, Branded Medicines – Tranche A and Annual TrancheThe NHS Commissioning Board (operating under the name of NHS England)
NHS Framework Agreement for Branded Medicines – NationalNHS England
NHS Framework Agreement for Branded Medicines – NationalNHS England
NHS Branded Medicines Tranche A - London & SOFE & Adult Influenza NationalNHS England24 Jun 2025£261.9m
NHS Framework Agreement for Branded Medicines - Proprietary Category TenderNHS England24 Mar 2025£1.2bn
NHS Branded Medicines Tranche Framework for London and South of EnglandNHS England21 Jul 2024£381m
NHS Branded Medicines Framework for North of England and Midlands and East - 1 March 2024NHS England26 Jan 2024£688m
NHS South of England Branded Medicines - Tranche A - September 2023NHS England17 Jul 2023£249.8m
NHS London Branded Medicines - Tranche B - September 2023NHS England13 Jul 2023£231.1m
NHS Framework Agreement-Branded Medicines - National Proprietary PharmaceuticalsNHS England23 Apr 2023£304.5m
NHS Midland & East Branded Medicines, Tranche B & Annual TrancheNHS England13 Feb 2023£480.4m
NHS Framework for North of England Branded Medicines Tranche A & Annual TrancheNHS England8 Feb 2023£262m
NHS Framework Agreement for South of England Branded - Tranche B and AnnualNHS England14 Jul 2022£338.7m
NHS Framework Agreement for London, Branded Medicines - Tranche A and AnnualNHS England14 Jul 2022£153.8m
NHS Framework for the North of England, Branded MedicineNHS England7 Feb 2022£238.9m
NHS Framework for the North of England, Branded MedicineNHS England7 Feb 2022£238.9m
NHS Framework for the North of England, Branded MedicineNHS England7 Feb 2022£238.9m
NHS Framework for Midlands and East, Branded Medicines - Tranche A and AnnualNHS England7 Feb 2022£216.1m
NHS Framework Agreement for Branded Medicines - NationalNHS England26 Sept 2021£95.2m
NHS Framework Agreement, Branded Medicines for London and South of EnglandNHS England18 Aug 2021£558.5m
NHS Framework Agreement, Branded Medicines for London and South of EnglandNHS England18 Aug 2021£558.5m
NHS Framework, North of England, Branded Medicines-Tranche A and Annual TrancheNHS England11 Feb 2021£203.6m
NHS Framework for the Midlands and East, Branded Medicines - Tranche BNHS England25 Jan 2021£228.2m
NHS Framework Agreement - North of England - Tranche BNHS England13 Feb 2020£205.5m
NHS National Agreement for the supply of Teriparatide (Interim Agreement)NHS England24 Sept 2019£7.4m
NHS Framework Agreement for Branded medicines - London - Tranche B - Contracts Finder OpportunityNHS England4 Jul 2019£251.9m
NHS Framework Agreement for Branded Medicines - NationalNHS England30 Apr 2019£1.4bn
NHS England - Midlands and East Branded Medicines - Tranche BNHS England17 Jan 2019£295m
NHS England - Midlands and East Branded Medicines - Tranche BNHS England17 Jan 2019£295m

Supplier identities

How this company appears as a supplier across the data.

FAQs about GEDEON RICHTER (UK) LIMITED

Is GEDEON RICHTER (UK) LIMITED an active company?

GEDEON RICHTER (UK) LIMITED (company number 04325685) is recorded as "Active", incorporated on 20 Nov 2001.

What does GEDEON RICHTER (UK) LIMITED do?

Its Companies House nature-of-business (SIC) is: 46180 - Agents specialized in the sale of other particular products; 46460 - Wholesale of pharmaceutical goods.

Has GEDEON RICHTER (UK) LIMITED won UK public-sector contracts?

Yes — 50 public-sector contract awards are linked to this company in our data.

Where is GEDEON RICHTER (UK) LIMITED based?

Its registered office is 127 SHIRLAND ROAD, LONDON, W9 2EP.

Understand any company's public-sector footprint

Enable links Companies House to live procurement and spend data — see contracts, buyers and payments for any UK supplier.

Get in touch with Enable